ARCHIVES

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

This article is from The Cancer Letter archive.

Vol. 26 No. 17 | April 28, 2000

Download PDF Visit The Full Archive

Related Articles

NCI CTEP Approved Trials For the Month of April

April 25, 2014

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

In Brief: Panel to Meet June 9 In Boston; Iverson Takes Position At U. Colo.’Namovicz Leaving NHLBI

May 23, 1986

Porter Softens Proposal To require SBIR Scores To Match R01s

July 26, 1996

Cancer Cases To Double By 2050 As U.S. Population Ages, Annual Report Says.

May 17, 2002

Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment.

July 30, 2004